UNIVERSAL HEALTH SVCS INC--FORM 8-K

FORM 8-K

 


 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 19, 2004

 


 

UNIVERSAL HEALTH SERVICES, INC.

(Exact name of registrant as specified in its charter)

 


 

DELAWARE   1-10765   23-2077891

(State or other jurisdiction of

Incorporation or Organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

UNIVERSAL CORPORATE CENTER

367 SOUTH GULPH ROAD

KING OF PRUSSIA, PENNSYLVANIA 19406

(Address of principal executive office) (Zip Code)

 

Registrant’s telephone number, including area code (610) 768-3300

 

Not Applicable

(Former name or former address, if changed since last report)

 



Item 7. Financial Statements and Exhibits.

 

(c) Exhibits. 99.1 Universal Health Services, Inc. Press Release dated February 18, 2004

 

Item 12. Results of Operations and Financial Condition

 

On February 18, 2004, Universal Health Services, Inc. (the “Company”) issued its 2003 fourth quarter and full year earnings release. A copy of the Company’s press release is furnished as an exhibit to this Form 8-K and is incorporated herein by reference.


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Universal Health Services, Inc.

By:

 

/s/ Alan B. Miller


Name:

 

Alan B. Miller

Title:

 

President and Chief Executive Officer

 

By:

 

/s/ Steve Filton


Name:

 

Steve Filton

Title:

 

Vice President, Chief Financial Officer

 

Date: February 19, 2004

 

Exhibit Index

 

Exhibit No.

 

Exhibit


99.1   Press release, dated February 18, 2004
PRESS RELEASE

EXHIBIT 99.1

 

FOR IMMEDIATE RELEASE

 

CONTACT:

 

Steve Filton

    
   

Chief Financial Officer

  

February 18, 2004

   

610-768-3300

    

 

UNIVERSAL HEALTH SERVICES, INC. REPORTS A 14% INCREASE IN

ADJUSTED EARNINGS PER DILUTED SHARE, ITS ELEVENTH

CONSECUTIVE ANNUAL INCREASE

 

KING OF PRUSSIA, PA — Universal Health Services, Inc. (NYSE: UHS) announced today its results for the fourth quarter and full year ended December 31, 2003. Reported net income was $46.5 million or $.75 per diluted share during the fourth quarter of 2003, as compared to $43.9 million or $.69 per diluted share during the fourth quarter of 2002. For the full year of 2003, reported net income was $199.3 million or $3.20 per diluted share as compared to $175.4 million or $2.74 per diluted share during 2002.

 

Included in the reported results for the fourth quarter ended December 31, 2003 were the following items (as listed on the attached schedule of Supplemental Consolidated Income Statement Information): (i) a previously disclosed after-tax increase of $5.6 million or $.08 per diluted share resulting from the reversal of an accrued liability (including accrued interest) due to a favorable Texas Supreme Court decision which reversed an unfavorable 2000 jury verdict and 2001 appellate court decision; (ii) an after-tax increase of $4.3 million or $.07 per diluted share resulting from a gain realized on the disposition of an investment in a health-care related company, and; (iii) an after-tax reduction of $8.7 million or $.13 per diluted share resulting from the write-down of the carrying value of an acute care pediatric hospital located in Puerto Rico to its estimated realizable value. Included in the reported results for the year ended December 31, 2003, in addition to the fourth quarter items mentioned above, were previously disclosed after-tax (and after-minority interest) gains amounting to $4.4 million or $.07 per diluted share realized on the sales of radiation therapy centers, medical office buildings and an outpatient surgery center, all of which were sold during the third quarter ended September 30, 2003.

 

Excluding the items listed above from the three month period ended December 31, 2003 and excluding an after-tax recovery of closure costs of $1.4 million or $.02 per diluted share included in the three month period ended December 31, 2002, adjusted net


income and adjusted earnings per diluted share (both as calculated on the attached Schedule of Consolidated Income Statement Information) increased 6% to $45.3 million and 9% to $.73, respectively, during the fourth quarter of 2003 as compared to $42.5 million and $.67, respectively, in the prior year quarter. Net revenues increased 14% during the three month period ended December 31, 2003 to $949.5 million as compared to $835.5 million during the prior year’s fourth quarter. During the quarter ended December 31, 2003, EBITDA (as calculated on the attached schedule of Supplemental Consolidated Income Statement Information) increased 10% to $121.5 million as compared to $110.7 million during the prior year’s fourth quarter.

 

For the year ended December 31, 2003, adjusted net income and adjusted earnings per diluted share increased 11% and 14%, respectively, to $193.7 million and $3.11 as compared to $174.0 million and $2.72, respectively, during 2002. During 2003, net revenues increased 12% to $3.64 billion as compared to $3.26 billion during 2002. EBITDA increased 13% during 2003 to $490.7 million as compared to $434.6 million during 2002.

 

Chairman and CEO Alan Miller said, “Our hospitals owe their success to a responsive management style, and to a service philosophy that is based on integrity, competence and compassion. The UHS strategy is to build or purchase health care properties in rapidly growing markets, and then create a strong franchise based on exceptional service and effective cost control. The efforts of the many talented people at UHS produced solid financial results even though hospitals continue to be challenged by sluggish volumes. In addition to continuing to invest aggressively to provide the health care needed by our existing communities, UHS will also continue to look selectively to acquire hospitals where we believe our skills can improve the quality and financial viability of the hospital.”

 

The growth in revenues and earnings was attained despite no growth in acute care admissions. Admissions to the Company’s acute care hospitals located in the U.S. and Puerto Rico owned for more than a year decreased 2.5% during the fourth quarter of 2003 as compared to the prior year’s fourth quarter. Admissions to the Company’s behavioral health care facilities owned more than a year increased 5.5% during the fourth quarter of 2003 as compared to the prior year’s fourth quarter. Contributing to the increase in revenues and earnings during the fourth quarter of 2003, as compared to the prior year quarter, was a 6.8% increase in net revenue per adjusted admission achieved at the Company’s acute care hospitals located in the U.S. and Puerto Rico. Net revenue per adjusted admission at the Company’s behavioral health hospitals increased 2.4% during the quarter.


Admissions to the Company’s acute care hospitals located in the U.S. and Puerto Rico owned for more than a year decreased .5% during 2003 as compared to the prior year while admissions to the Company’s behavioral health care facilities owned more than a year increased 2.9% during 2003 as compared to 2002. Net revenue per adjusted admission at the Company’s acute care hospitals located in the U.S. and Puerto Rico increased 7.3% during 2003 as compared to the prior year. Net revenue per adjusted admission at the Company’s behavioral health hospitals increased 3.3% during the year as compared to 2002.

 

Cash flow from operations for the full year was $374 million, an increase of 13% from the prior year. During 2003, the Company invested $224 million in capital expenditures and purchased 1.36 million of its shares for $54 million. By year-end 2003, the Company’s shareholders’ equity increased 19% to $1.091 billion. The Company also spent $278 million on hospital acquisitions, including $230 million spent on December 31, 2003 to acquire four acute care facilities (three located in California and one in Louisiana acquired effective January 1, 2004). The Company’s return on capital, defined as adjusted net income divided by the sum of debt (excluding the $230 million spent on December 31, 2003 to purchase four acute care hospitals) plus shareholders’ equity, increased to 11.1% in 2003 as compared to 10.8% in 2002.

 

The Company’s provision for doubtful accounts was 7.8% of net revenues during the fourth quarter of 2003 as compared to 6.9% during the prior year’s fourth quarter. The increase resulted primarily from an increase in uninsured and self-pay patients which unfavorably impacts the collectibility of our patient accounts. We expect this trend to continue until there is a notable strengthening of the labor market.

 

Management of the Company believes that operating income, operating margin, EBITDA, adjusted net income and adjusted earnings per diluted share (as calculated on the attached schedules of Supplemental Consolidated Income Statement Information), which are non-GAAP financial measures, are helpful to our investors as measures of our operating performance. Since the source of financing for the purchase of property and equipment and other assets at each hospital varies, we believe that measuring operating performance before capital-related costs (such as depreciation and amortization, lease and rental and interest expense) provides a useful comparison of relative operating performance among our facilities. Operating income and operating margin are used by management as analytical indicators for purposes of assessing the relative operating performance of our individual hospitals and operating segments, and the overall Company. Also, our use of operating income, operating margin and EBITDA enables investors to compare our performance with that of others in the industry. In addition, we believe that comparing and discussing our financial results based on adjusted net income and adjusted earnings per diluted share, is helpful to our investors since it neutralizes the


effect in each period, of items that are nonrecurring or non-operating in nature such as recovery of prior year provisions for judgment/closure costs, gains on sales of assets and businesses and provision for asset impairment.

 

To obtain a complete understanding of our financial performance, operating income, operating margin, EBITDA, adjusted net income and adjusted net income per diluted share should be examined in connection with net income determined in accordance with generally accepted accounting principles, as presented in these financial statements as well as information provided elsewhere such as the Company’s Reports on Forms 10-Q and 10-K. Since the items excluded from operating income, operating margin, EBITDA, adjusted net income and adjusted earnings per diluted share are significant components in understanding and assessing financial performance under generally accepted accounting principles, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Because these measures are not determined in accordance with generally accepted accounting principles and are thus susceptible to varying calculations, operating income, operating margin, EBITDA, adjusted net income and adjusted earnings per diluted share as presented may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

 

This press release contains forward-looking statements based on current management expectations. Numerous factors, including those related to healthcare industry trends and those detailed in the Company’s filings with the Securities and Exchange Commission (as set forth on page 16 of the Company’s Form 10-Q for the quarterly period ended September 30, 2003), may cause results to differ materially from those anticipated in the forward-looking statements. Many of the factors that will determine the Company’s future results are beyond the ability of the Company to control or predict. These statements are subject to risks and uncertainties and therefore actual results may differ materially. Readers should not place undue reliance on such forward-looking statements which reflect management’s view only as of the date hereof. The Company undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

 

Universal Health Services, Inc. is one of the nation’s largest hospital companies, operating acute care and behavioral health hospitals and ambulatory centers nationwide, in Puerto Rico and in France. It acts as the advisor to Universal Health Realty Income Trust, a real estate investment trust (NYSE: UHT).

 

For additional information on the Company, visit our web site: http://www.uhsinc.com.


Universal Health Services, Inc.

Consolidated Statements of Income

(in thousands, except per share amounts)

 

     Three months ended
December 31,


    Twelve months ended
December 31,


 
     2003

    2002

    2003

    2002

 

Net revenues

   $ 949,472     $ 835,478     $ 3,643,566     $ 3,258,898  

Operating charges:

                                

Salaries, wages and benefits

     381,725       334,334       1,457,395       1,298,967  

Other operating expenses

     219,545       201,209       848,495       787,408  

Supplies expense

     133,755       111,395       495,945       425,142  

Provision for doubtful accounts

     74,314       58,033       263,724       231,362  

Depreciation and amortization

     38,617       34,350       144,466       124,794  

Lease and rental expense

     16,401       15,623       64,077       61,712  

Provision for asset impairment

     13,742       0       13,742       0  
    


 


 


 


       878,099       754,944       3,287,844       2,929,385  
    


 


 


 


Income before interest expense, recovery of provision for judgment/closure costs, gains on sales of assets and businesses, minority interests, and income taxes

     71,373       80,534       355,722       329,513  

Interest expense, net

     10,394       9,198       38,233       34,966  

Recovery of provision for judgment/closure costs

     (8,867 )     (2,182 )     (8,867 )     (2,182 )

Gains on sales of assets and businesses

     (6,786 )     0       (14,623 )     0  

Minority interests in earnings of consolidated entities

     2,244       4,173       23,280       19,658  
    


 


 


 


Income before income taxes

     74,388       69,345       317,699       277,071  

Provision for income taxes

     27,920       25,455       118,430       101,710  
    


 


 


 


Net income

   $ 46,468     $ 43,890     $ 199,269     $ 175,361  
    


 


 


 


Earnings per common share - basic

   $ 0.81     $ 0.74     $ 3.45     $ 2.94  
    


 


 


 


Earnings per common share - diluted

   $ 0.75     $ 0.69     $ 3.20     $ 2.74  
    


 


 


 


EARNINGS PER SHARE CALCULATION

                                

Net income

   $ 46,468     $ 43,890     $ 199,269     $ 175,361  

Less: Dividends on unvested restricted stock, net of taxes

     (28 )     0       (28 )     0  
    


 


 


 


Adjusted net income - basic

     46,440       43,890       199,241       175,361  

Add: Debenture interest, net of taxes

     2,222       2,134       8,799       8,451  
    


 


 


 


Adjusted net income - diluted

   $ 48,662     $ 46,024     $ 208,040     $ 183,812  

Weighted average number of common shares - basic

     57,466       59,241       57,688       59,730  

Add: Shares for conversion of convertible debentures

     6,577       6,577       6,577       6,577  

Other share equivalents

     935       1,005       824       768  
    


 


 


 


Weighted average number of common shares and equiv. - diluted

     64,978       66,823       65,089       67,075  

Earnings per common share - basic

   $ 0.81     $ 0.74     $ 3.45     $ 2.94  
    


 


 


 


Earnings per common share - diluted

   $ 0.75     $ 0.69     $ 3.20     $ 2.74  
    


 


 


 



Universal Health Services, Inc.

Condensed Consolidated Balance Sheets

(in thousands)

 

     December 31,
2003


   December 31,
2002


Assets:

             

Cash and cash equivalents

   $ 34,863    $ 17,750

Accounts receivable, net

     503,929      474,763

Other current assets

     106,999      101,105

Property, plant and equipment, net

     1,304,341      1,173,195

Other assets

     822,598      562,324
    

  

     $ 2,772,730    $ 2,329,137
    

  

Liabilities and Stockholders’ Equity:

             

Current portion of long-term debt

   $ 10,871    $ 8,253

Other current liabilities

     384,882      362,160

Other noncurrent liabilities

     216,094      206,238

Minority interest

     159,554      140,247

Long-term debt

     868,566      680,514

Deferred income taxes

     41,841      14,266

Stockholders’ equity

     1,090,922      917,459
    

  

     $ 2,772,730    $ 2,329,137
    

  


Universal Health Services, Inc.

Supplemental Consolidated Income Statement Information

(in thousands)

unaudited

 

     Three months ended
December 31, 2003


    Three months ended
December 31, 2002


 

Net revenues

   $ 949,472       100.0 %   $ 835,478       100.0 %

Operating charges:

                                

Salaries, wages and benefits

     381,725       40.2 %     334,334       40.0 %

Other operating expenses

     219,545       23.1 %     201,209       24.1 %

Supplies expense

     133,755       14.1 %     111,395       13.3 %

Provision for doubtful accounts

     74,314       7.8 %     58,033       6.9 %
    


 


 


 


       809,339       85.2 %     704,971       84.4 %
    


 


 


 


Operating income/margin

     140,133       14.8 %     130,507       15.6 %

Lease and rental expense

     16,401               15,623          

Minority interests in earnings of consolidated entities

     2,244               4,173          
    


         


       

Earnings before depreciation and amortization, interest expense, recovery of provision for judgment/closure costs, gains on sales of assets and businesses, provision for asset impairment and income taxes (“EBITDA”)

     121,488               110,711          

Depreciation and amortization

     38,617               34,350          

Interest expense, net

     10,394               9,198          

Recovery of provision for judgment/closure costs

     (8,867 )             (2,182 )        

Gains on sales of assets and businesses

     (6,786 )             0          

Provision for asset impairment

     13,742               0          
    


         


       

Income before income taxes

     74,388               69,345          

Provision for income taxes

     27,920               25,455          
    


         


       

Net income

   $ 46,468             $ 43,890          
    


         


       
     Amount

    Per
Diluted Share


    Amount

    Per
Diluted Share


 

Calculation of Adjusted Net Income

                                

Net income

   $ 46,468     $ 0.75     $ 43,890     $ 0.69  

Less: After-tax recovery of provision for judgment/closure costs

     (5,590 )   $ (0.08 )     (1,376 )   $ (0.02 )

Less: After-tax and minority interest gains on sales of assets and businesses

     (4,279 )   $ (0.07 )     —         —    

Plus: After-tax charge on provision for asset impairment

     8,664     $ 0.13       —         —    
    


 


 


 


Adjusted net income

   $ 45,263     $ 0.73     $ 42,514     $ 0.67  
    


 


 


 



Universal Health Services, Inc.

Supplemental Consolidated Income Statement Information

(in thousands)

unaudited

 

    

Twelve months ended

December 31, 2003


   

Twelve months ended

December 31, 2002


 

Net revenues

   $ 3,643,566       100.0 %   $ 3,258,898       100.0 %

Operating charges:

                                

Salaries, wages and benefits

     1,457,395       40.0 %     1,298,967       39.9 %

Other operating expenses

     848,495       23.3 %     787,408       24.2 %

Supplies expense

     495,945       13.6 %     425,142       13.0 %

Provision for doubtful accounts

     263,724       7.2 %     231,362       7.1 %
    


 


 


 


       3,065,559       84.1 %     2,742,879       84.2 %
    


 


 


 


Operating income/margin

     578,007       15.9 %     516,019       15.8 %

Lease and rental expense

     64,077               61,712          

Minority interests in earnings of consolidated entities

     23,280               19,658          
    


         


       

Earnings before depreciation and amortization, interest expense, recovery of provision for judgment/closure costs, gains on sales of assets and businesses, provision for asset impairment and income taxes (“EBITDA”)

     490,650               434,649          

Depreciation and amortization

     144,466               124,794          

Interest expense, net

     38,233               34,966          

Recovery of provision for judgment/closure costs

     (8,867 )             (2,182 )        

Gains on sales of assets and businesses

     (14,623 )             0          

Provision for asset impairment

     13,742               0          
    


         


       

Income before income taxes

     317,699               277,071          

Provision for income taxes

     118,430               101,710          
    


         


       

Net income

   $ 199,269             $ 175,361          
    


         


       
     Amount

    Per
Diluted Share


    Amount

    Per
Diluted Share


 

Calculation of Adjusted Net Income

                                

Net income

   $ 199,269     $ 3.20     $ 175,361     $ 2.74  

Less: After-tax recovery of provision for judgment/closure costs

     (5,590 )   $ (0.08 )     (1,376 )   $ (0.02 )

Less: After-tax and minority interest gains on sales of assets and businesses

     (8,675 )   $ (0.14 )     —         —    

Plus: After-tax charge on provision for asset impairment

     8,664     $ 0.13       —         —    
    


 


 


 


Adjusted net income

   $ 193,668     $ 3.11     $ 173,985     $ 2.72  
    


 


 


 



UNIVERSAL HEALTH SERVICES, INC.

SELECTED HOSPITAL STATISTICS

DECEMBER 31, 2003

 

AS REPORTED:

 

     FOR THE THREE MONTHS ENDED

 
     ACUTE (1)

          BEHAVIORAL
HEALTH


       
     12/31/03

    12/31/02

    %

    12/31/03

    12/31/02

    %

 

Hospitals owned and leased

     25       25     0.0 %     39       37     5.4 %

Average licensed beds

     6,010       5,713     5.2 %     3,902       3,754     3.9 %

Patient days

     315,139       310,478     1.5 %     265,733       248,708     6.8 %

Average daily census

     3,425.4       3,374.8     1.5 %     2,888.4       2,703.3     6.8 %

Occupancy-licensed beds

     57.0 %     59.1 %   -3.5 %     74.0 %     72.0 %   2.8 %

Admissions

     66,990       67,395     -0.6 %     21,756       20,379     6.8 %

Length of stay

     4.7       4.6     2.1 %     12.2       12.2     0.1 %

Inpatient revenue

   $ 1,525,554     $ 1,384,584     10.2 %   $ 274,269     $ 241,497     13.6 %

Outpatient revenue

     551,708       474,790     16.2 %     40,600       37,434     8.5 %

Total patient revenue

     2,077,262       1,859,374     11.7 %     314,869       278,931     12.9 %

Other revenue

     11,392       13,865     -17.8 %     7,432       7,923     -6.2 %

Gross hospital revenue

     2,088,654       1,873,239     11.5 %     322,301       286,854     12.4 %

Total deductions

     1,396,707       1,224,075     14.1 %     167,501       147,211     13.8 %

Net hospital revenue

   $ 691,947     $ 649,164     6.6 %   $ 154,800     $ 139,643     10.9 %

 

SAME FACILITY:

 

     FOR THE THREE MONTHS ENDED

 
     ACUTE (1) (2)

          BEHAVIORAL
HEALTH (3)


       
     12/31/03

    12/31/02

    %

    12/31/03

    12/31/02

    %

 

Hospitals owned and leased

   25     25     0.0 %   37     37     0.0 %

Average licensed beds

   5,834     5,713     2.1 %   3,785     3,754     0.8 %

Patient days

   310,666     310,482     0.1 %   256,340     248,722     3.1 %

Average daily census

   3,376.8     3,374.8     0.1 %   2,786.3     2,703.5     3.1 %

Occupancy-licensed beds

   57.9 %   59.1 %   -2.0 %   73.6 %   72.0 %   2.2 %

Admissions

   65,734     67,395     -2.5 %   21,508     20,379     5.5 %

Length of stay

   4.7     4.6     2.6 %   11.9     12.2     -2.3 %

(1) Does not include hospitals located in France
(2) Spring Valley Hospital is excluded in both years
(3) North Star Hospital and Residential Center are excluded in both current and prior years.


UNIVERSAL HEALTH SERVICES, INC.

SELECTED HOSPITAL STATISTICS

DECEMBER 31, 2003

 

AS REPORTED:

 

     FOR THE TWELVE MONTHS ENDED

 
     ACUTE (1)

         

BEHAVIORAL

HEALTH


       
     12/31/03

    12/31/02

    %

    12/31/03

    12/31/02

    %

 

Hospitals owned and leased

     25       25     0.0 %     39       37     5.4 %

Average licensed beds

     5,804       5,813     -0.2 %     3,894       3,752     3.8 %

Patient days

     1,247,882       1,239,040     0.7 %     1,067,200       1,005,882     6.1 %

Average daily census

     3,418.9       3,394.6     0.7 %     2,923.8       2,755.8     6.1 %

Occupancy-licensed beds

     58.9 %     58.4 %   0.9 %     75.1 %     73.4 %   2.2 %

Admissions

     266,207       266,261     0.0 %     87,688       84,348     4.0 %

Length of stay

     4.7       4.7     0.7 %     12.2       11.9     2.1 %

Inpatient revenue

   $ 5,947,211     $ 5,183,944     14.7 %   $ 1,091,885     $ 979,824     11.4 %

Outpatient revenue

     2,140,781       1,814,757     18.0 %     156,115       149,604     4.4 %

Total patient revenue

     8,087,992       6,998,701     15.6 %     1,248,000       1,129,428     10.5 %

Other revenue

     51,337       58,609     -12.4 %     33,345       36,021     -7.4 %

Gross hospital revenue

     8,139,329       7,057,310     15.3 %     1,281,345       1,165,449     9.9 %

Total deductions

     5,413,741       4,533,018     19.4 %     668,941       599,864     11.5 %

Net hospital revenue

   $ 2,725,588     $ 2,524,292     8.0 %   $ 612,404     $ 565,585     8.3 %

 

SAME FACILITY:

 

     FOR THE TWELVE MONTHS ENDED

 
     ACUTE (1) (2)

          BEHAVIORAL
HEALTH (3)


       
     12/31/03

    12/31/02

    %

    12/31/03

    12/31/02

    %

 

Hospitals owned and leased

   25     25     0.0 %   37     37     0.0 %

Average licensed beds

   5,760     5,813     -0.9 %   3,777     3,752     0.7 %

Patient days

   1,243,482     1,239,139     0.4 %   1,032,950     1,005,867     2.7 %

Average daily census

   3,406.8     3,394.9     0.4 %   2,830.0     2,755.8     2.7 %

Occupancy-licensed beds

   59.1 %   58.4 %   1.3 %   74.9 %   73.4 %   2.0 %

Admissions

   264,951     266,261     -0.5 %   86,786     84,348     2.9 %

Length of stay

   4.7     4.7     0.8 %   11.9     11.9     -0.2 %

(1) Does not include hospitals located in France
(2) Spring Valley Hospital is excluded in both years
(3) North Star Hospital and Residential Center are excluded in both current and prior years.


Universal Health Services, Inc.

Supplemental Statistical Information

(un-audited)

 

Same Facility:

 

     % Change
Quarter Ended
12/31/2003


    % Change
12 mos. ended
12/31/2003


 

Acute Care Hospitals

            

Revenues

   5.3 %   7.6 %

Adjusted Admissions

   -1.4 %   0.3 %

Adjusted Patient Days

   0.8 %   1.0 %

Revenue Per Adjusted Admission

   6.8 %   7.3 %

Revenue Per Adjusted Patient Day

   4.4 %   6.6 %

Behavioral Health Hospitals

            

Revenues

   7.0 %   5.5 %

Adjusted Admissions

   4.5 %   2.2 %

Adjusted Patient Days

   2.4 %   2.1 %

Revenue Per Adjusted Admission

   2.4 %   3.3 %

Revenue Per Adjusted Patient Day

   4.5 %   3.3 %

 

UHS Consolidated

 

     Fourth Quarter Ended

    Twelve months Ended

 
     12/31/2003

    12/31/2002

    12/31/2003

    12/31/2002

 

Revenues

   $ 949,472     $ 835,478     $ 3,643,566     $ 3,258,898  

EBITDA (1)

   $ 121,488     $ 110,711     $ 490,650     $ 434,649  

EBITDA Margin (1)

     12.8 %     13.3 %     13.5 %     13.3 %

Cash Flow From Operations

   $ 60,329     $ 86,078     $ 373,731     $ 331,259  

Days Sales Outstanding

     49       52       50       53  

Capital Expenditures (including acquisitions)

   $ 280,282     $ 40,627     $ 477,218     $ 201,469  

Debt (net of cash)

     —         —       $ 844,574     $ 671,017  

Shareholders Equity

     —         —       $ 1,090,922     $ 917,459  

Debt / Total Capitalization

     —         —         43.6 %     42.2 %

Debt / EBITDA (2)

     —         —         1.72       1.54  

Debt / Cash From Operations (2)

     —         —         2.26       2.03  

Acute Care EBITDAR Margin (3)

     14.7 %     17.1 %     17.2 %     17.3 %

Behavioral Health EBITDAR Margin (3)

     25.4 %     20.4 %     23.5 %     20.3 %

(1) Net of Minority Interest
(2) Latest 4 quarters
(3) Before Corporate overhead allocation and minority interest